PHOENIX, Aug. 28 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA) today announced that Frank J. Bellizzi, DMD, president of Zila Pharmaceuticals, will present a company overview at the Roth 2007 New York Conference on Wednesday, September 5, 2007 at 4:30 p.m. ET at The Westin New York Hotel at Times Square.
Interested parties can listen to the presentation through a live webcast at the Zila Web site, http://www.zila.com/. Listeners are encouraged to visit the Web site at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. For those unable to listen to the live webcast, the presentation will be archived on the same Web site for approximately 90 days.
About Zila, Inc.
Zila, Inc., headquartered in Phoenix, is an oral cancer screening company focused on the prevention and treatment of oral disease.
Zila is dedicated to establishing ViziLite(R) Plus as the new standard of care for the early detection of oral abnormalities that could lead to cancer, with an initial focus on the dental market through Pro-Dentec(R), a leading designer, manufacturer and marketer of Soft Tissue Management (STM(R)) products. Sold exclusively and directly to dental professionals, Pro-Dentec's core products include the Rota-dent(R) Professional Powered Brush, the Pro- Select3(R) Piezo-Ultrasonic Scaler System and a suite of pharmaceutical STM(R) products for both in-office and home-care use.
For more information about Zila, visit http://www.zila.com/. DATASOURCE: Zila, Inc.
CONTACT: Robert Jaffe of PondelWilkinson Inc. for Zila, Inc., +1-310-279-5969 Web site: http://www.zila.com/
|